Health Canada drug identification number

DIN 01997572 — DANTRIUM INTRAVENOUS 20 MG

DANTRIUM INTRAVENOUS is a powder for solution of Dantrolene marketed by KNIGHT THERAPEUTICS INC.. The full Dantrolene monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
01997572
Brand name
DANTRIUM INTRAVENOUS
Active ingredient
Dantrolene
Strength
20 MG
Dosage form
POWDER FOR SOLUTION
Route
INTRAVENOUS
Manufacturer
KNIGHT THERAPEUTICS INC.
Health Canada status
MARKETED
Drug class
Direct-acting skeletal muscle relaxant (hydantoin derivative)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Dantrolene products

DINBrandStrengthFormManufacturerStatus
01997602 DANTRIUM CAPSULES 25 MG CAPSULE KNIGHT THERAPEUTICS INC. MARKETED
02529998 DANTROLENE SODIUM FOR INJECTION, USP 20 MG POWDER FOR SOLUTION HIKMA CANADA LIMITED MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.